Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease-antibiotic use in the history does not play a significant role

被引:40
|
作者
Prónai, L [1 ]
Schandl, L
Orosz, Z
Magyar, P
Tulassay, Z
机构
[1] Semmelweis Univ, Hungarian Acad Sci, Fac Med, Dept Med 2,Gastroenterol Res Unit, Budapest, Hungary
[2] Semmelweis Univ, Dept Pulmonol, H-1088 Budapest, Hungary
关键词
Helicobacter pylori; inflammatory bowel disease; Crohn's disease; ulcerative colitis; chronic obstructive pulmonary disease;
D O I
10.1111/j.1083-4389.2004.00223.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Patients with inflammatory bowel disease have lower prevalence of Helicobacter pylori infection, but the exact reason for this is not yet clear. Aim. To examine whether the antibiotics frequently used in inflammatory bowel disease are responsible for the lower prevalence of H. pylori infection. Patients with chronic obstructive pulmonary disease on prolonged previous antibiotic therapy were used for comparison. Methods. Presence/absence of H. pylori infection was detected by a C-13-urea breath test in 133 patients with inflammatory bowel disease (82 ulcerative colitis, and 51 Crohn's disease) and compared with that of 135 patients with chronic obstructive pulmonary disease and with two age-matched control groups (200 patients each). Primary disease location, duration of disease and detailed analysis of previous and current medication (dose and duration of antibiotics, steroids, 5-aminosalicylic acid) were analysed in each cases. Results. Seventeen of the 133 patients with inflammatory bowel disease [12.2% (10/82) of ulcerative colitis and 13.7% (7/51) of Crohn's disease] and 90/135 patients with chronic obstructive pulmonary disease (66.7%) were positive for H. pylori. A total of 78/200 (39%) for the inflammatory-bowel-discase-group-matched controls and 110/210 (55%) for the chronic-obstructive-pulmonary-disease-matched controls were positive for H. pylori. The history of any antibiotic or steroid therapy had no influence on H. pylori status of patients with inflammatory bowel disease. Conclusion. The prevalence of H. pylori compared to the age-matched controls is significantly lower in patients with inflammatory bowel disease but not in those with chronic obstructive pulmonary disease. Antibiotic use is not responsible for the lower prevalence of H. pylori infection in patients with inflammatory bowel disease.
引用
收藏
页码:278 / 283
页数:6
相关论文
共 50 条
  • [21] DOES HELICOBACTER-PYLORI HAVE A ROLE IN INFLAMMATORY BOWEL-DISEASE
    STURNIOLO, GC
    DINCA, R
    RUGGE, M
    CASSARO, M
    CALLEGARI, I
    SCIBILIA, C
    NACCARATO, R
    GASTROENTEROLOGY, 1994, 106 (04) : A187 - A187
  • [22] Treatment of inflammatory bowel disease patients with anti-TNF-α factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection
    John K. Triantafillidis
    Aristofanis Gikas
    Emmanuel Merikas
    Indian Journal of Gastroenterology, 2014, 33 (4) : 383 - 384
  • [23] The prevalence of Helicobacter pylori infection and inflammatory bowel disease: A single-center experience
    Cho, Jae Ho
    Lee, Dong Ho
    Shin, Cheol Min
    Song, Dong Jin
    Yoon, Hyuk
    Park, Young Soo
    Kim, Nayoung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 353 - 353
  • [24] The low prevalence of Helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment
    Triantafillidis, JK
    Gikas, A
    Apostolidiss, N
    Merikas, E
    Mallass, E
    Peros, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05): : 1213 - 1214
  • [25] Antibiotic use in patients hospitalized with chronic obstructive pulmonary disease
    Amin, Alpesh N.
    Ganapathy, Vaidyanathan
    Netzer, Logan
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (17) : 1268 - 1269
  • [26] Treatment of inflammatory bowel disease patients with anti-TNF-alpha factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection
    Triantafillidis, John
    Gikas, Aristofanis
    Merikas, Emmanuel
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2014, 33 (04) : 383 - 384
  • [27] The role of the intestinal microbiota in the etiology of inflammatory bowel disease and the impact of Helicobacter pylori infection
    Castano-Rodriguez, N.
    Popple, G.
    Kaakoush, N. O.
    Lee, W. S.
    Mitchell, H. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 116 - 116
  • [28] Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract
    Yang Yu
    Shengtao Zhu
    Peng Li
    Li Min
    Shutian Zhang
    Cell Death & Disease, 9
  • [29] Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract
    Yu, Yang
    Zhu, Shengtao
    Li, Peng
    Min, Li
    Zhang, Shutian
    CELL DEATH & DISEASE, 2018, 9
  • [30] Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease:: Does H-pylori protect from Crohn's disease?
    Väre, PO
    Heikius, B
    Silvennoinen, JA
    Karttunen, R
    Niemelä, SE
    Lehtola, JK
    Karttunen, TJ
    GUT, 2000, 47 : A88 - A89